Neuralstem NSI-189 Select Data To Be Presented At Neuropsychopharmacology Congress

A poster entitled, "Effects of NSI-189, a neurogenic compound, on quantitative electroencephalography in patients with major depressive disorder during a phase 1b randomized, double-blinded, placebo controlled, multiple ascending dose study," will be presented in the session "Biomarkers for diagnosis and treatment response" on During the course of ... (more)

http://ift.tt/Uh3MXd